Together with other clinical changes, increased oxidative stress and proinflammatory cytokines (IFN-γ and TNF-α) can plausibly be implicated in immune balance shifts towards a decrease in COVID-19-specific antibodies. This evidence concerns the gene TNF and COVID-19.